SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study.

Saved in:
Bibliographic Details
Title: SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study.
Authors: Shields AM; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. a.m.shields@bham.ac.uk.; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. a.m.shields@bham.ac.uk., Faustini SE; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Hill HJ; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Al-Taei S; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Tanner C; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Ashford F; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Workman S; Department of Immunology, Royal Free London NHS Foundation Trust, London, UK., Moreira F; Department of Immunology, Royal Free London NHS Foundation Trust, London, UK., Verma N; Department of Immunology, Royal Free London NHS Foundation Trust, London, UK., Wagg H; Institute of Translational Medicine, University of Birmingham, Birmingham, UK., Heritage G; Institute of Translational Medicine, University of Birmingham, Birmingham, UK., Campton N; Institute of Translational Medicine, University of Birmingham, Birmingham, UK., Stamataki Z; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Klenerman P; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Thaventhiran JED; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, CB2 1QW, UK., Goddard S; Department of Clinical Immunology, University Hospitals North Midlands, Stoke-on-Trent, UK., Johnston S; Department of Clinical Immunology, North Bristol NHS Trust, Bristol, UK., Huissoon A; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Bethune C; Department of Allergy and Clinical Immunology, University Hospitals Plymouth NHS Trust, Plymouth, UK., Elcombe S; Department of Allergy and Clinical Immunology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Lowe DM; Department of Immunology, Royal Free London NHS Foundation Trust, London, UK.; Institute of Immunity and Transplantation, University College London, London, UK., Patel SY; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; NIHR BRC Oxford Biomedical Centre, University of Oxford, Oxford, UK., Savic S; Department of Allergy and Clinical Immunology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Burns SO; Department of Immunology, Royal Free London NHS Foundation Trust, London, UK. siobhan.burns@ucl.ac.uk.; Institute of Immunity and Transplantation, University College London, London, UK. siobhan.burns@ucl.ac.uk., Richter AG; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. a.g.richter@bham.ac.uk.; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. a.g.richter@bham.ac.uk.
Corporate Authors: COV-AD consortium
Source: Journal of clinical immunology [J Clin Immunol] 2022 Jul; Vol. 42 (5), pp. 923-934. Date of Electronic Publication: 2022 Apr 14.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2592 (Electronic) Linking ISSN: 02719142 NLM ISO Abbreviation: J Clin Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-2592
DOI:10.1007/s10875-022-01231-7